A Study of TG103 Injection Monotherapy in Treatment of Type 2 Diabetes Mellitus
Clinical trial NCT06258148 · COMPLETED
Trial details
- NCT number
- NCT06258148
- Sponsor
- CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-15
- Primary completion
- 2026-01-23
- Enrollment
- 465
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.